Medtronic wins CE mark for Evolut FX+
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) system.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) system.
MOUNTAIN VIEW, Calif., Oct. 24, 2024 /PRNewswire/ — In a groundbreaking advancement for medical science, surgeons in Santiago, Chile, performed the world’s first robotic surgeries combining 3D visualization and augmented reality (AR), marking a significant step forward in improving surgical speed, visualization, precision, and patient outcomes.
SEOUL, South Korea, Oct. 24, 2024 /PRNewswire/ — Sky Labs’ CART BP, an innovative blood pressure monitoring device, has been recognized by the International Society of Hypertension (ISH) for its exceptional accuracy in both day and night measurements.
Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system with the Sphere-9 catheter.